Jeff Del Carmen

Jeff Del Carmen

Corporate Officer/Principal chez CATALYST PHARMACEUTICALS, INC.

Fortune : 450 612 $ au 30/06/2026

55 ans
Health Technology
Consumer Services
Commercial Services

Profil

Jeff Del Carmen is Chief Commercial Officer & Executive VP at Catalyst Pharmaceuticals, Inc. since 2024, with employment at the same company starting in 2018.
Former roles include Director-National Sales at Lundbeck, Inc. from 2011 to 2016, Senior Director-Rare Disease Marketing at Marathon Pharmaceuticals LLC from 2016 to 2017, Vice President-Sales at INSYS Therapeutics, Inc. in 2016, and Vice President-Business Development at Paragon Biosciences LLC.
Education includes an MBA from the University of Wisconsin and an undergraduate degree from the University of Dayton.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/06/2026 14 337 ( 0,01 % ) 450 612 $ 30/06/2026

Postes actifs de Jeff Del Carmen

SociétésPosteDébut
CATALYST PHARMACEUTICALS, INC. Corporate Officer/Principal 23/06/2020

Anciens postes connus de Jeff Del Carmen

SociétésPosteFin
Corporate Officer/Principal 01/07/2017
INSYS THERAPEUTICS, INC. Sales & Marketing 01/07/2016
Sales & Marketing 01/08/2011
Corporate Officer/Principal -
Voir l'expérience en détail de Jeff Del Carmen

Formation de Jeff Del Carmen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

18

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Jeff Del Carmen
🔇